We’re growing our team at Emmace! Please give a warm welcome to our team members, Johannes and Jonas! With demand growing for specialized expertise in Medical Device and Inhaled Drug Product Testing, we’re strengthening our team to better serve our clients and accelerate your development projects: Johannes Sjölin, BSc, joins us to boost our capacity
We’re growing our team at Emmace! Read More »
Scientific Understanding to Mitigate Risks in DPI Development: New Publication by Dr. Kyrre Thalberg In the development of Dry Powder Inhalers (DPIs), the path from formulation to regulatory approval is often fraught with technical challenges. One common cause of costly project delays is a lack of fundamental understanding of how drug particles interact with their
New Publication by Dr. Kyrre Thalberg Read More »
Congratulations Jamshaid Ashiq! Huge congratulations to our colleague, Muhammad Jamshaid Ashiq, on the publication of his latest research in Water, Air, & Soil Pollution! At Emmace Consulting, we pride ourselves on having world-class experts on our team. While Jamshaid is now a key part of our lab—focusing his expertise on VOS (Volatile Organic Substances) analysis — his previous
New Publication by Jamshaid Ashiq Read More »
Celebration and Opening our New Lab Space! What a year! We are celebrating Emmace’s best year ever. By opening our new lab space by multiplying our testing capacity of medical devices we are ready to offer even shorter lead times and even better service in 2026. A big thank you to our team and partners for making
What a year! Celebration and Opening our New Lab Space! Read More »
Download our checklist for preparation of ISO 18562-4 Condensate testing Emmace Insight: The Importance of Condensate Volume Determination According to ISO 18562-4 Background For medical device manufacturers, ensuring the safety of a product is paramount. When it comes to devices that interact with a patient’s respiratory system—the breathing gas pathway—specific biocompatibility standards must be fulfilled.
Welcome Tove, Lisa and Camilla to our team! Huge shoutout and a warm welcome to the newest talents joining our team! 🎉 We are incredibly excited to introduce (from left to right): Tove Sörnmo, Lisa Theorin, and Camilla Drott.We are so proud to have successfully recruited such outstanding professionals. Their unique expertise and energy are
Welcome Tove, Lisa and Camilla to our team! Read More »
Mårten Svensson Co-authors Scientific Publication Emmace Consulting is proud to announce that Mårten Svensson has co-authored a new and significant scientific article. Titled “Multi-Participant Blinded Investigation into Internal Losses of Medication in Commercially Available Mixing Inlets: Testing Different Orally Inhaled Product Classes Following Pharmacopeial Methods,” the article has been published in the J Aerosol Med.
Mårten Svensson Co-authors Scientific Publication Read More »
Emmace Achieves Accreditation for ISO 18562-4 Condensate Volume Determination We are pleased to announce that we have received accreditation from SWEDAC for our internally developed method for determining condensate volume of breathing gas pathways, adhering to ISO 18562-4. This significant achievement underscores Emmace’s dedication to providing cutting-edge biocompatibility testing of medical devices. This accreditation complements
Emmace Achieves Accreditation for ISO 18562-4 Condensate Volume Determination Read More »
Advancing Inhalation Drug Development: iBCS Framework in Focus A new publication co-authored by Per Bäckman, Senior Adviser at Emmace, marks the fourth paper in a series on the Inhalation Biopharmaceutics Classification System (iBCS). Published in Molecular Pharmaceutics, the study explores how iBCS can be applied throughout drug discovery, development, and regulatory evaluation for orally inhaled
Advancing Inhalation Drug Development: iBCS Framework in Focus Read More »
New Insights into Drug Distribution and Coating in Inhalation Powders A recent study by researchers at RISE and Emmace Consulting (Adj Prof Kyrre Thalberg), published in Surface and Interface Analysis, explores the molecular 3D distribution of budesonide and magnesium stearate (Mg-stearate) in dry powder inhalation formulations. Using advanced ToF-SIMS imaging and XPS analysis, the study reveals
New Insights into Drug Distribution and Coating in Inhalation Powders Read More »